Trupanion (TRUP) Investor Day 2024 summary

Business performance and financial guidance

• Achieved $1.2 million average daily claims paid, nearing $3 billion total since inception, with revenue predictability due to a subscription model and 36 quarters of 20%+ growth since 2014.

• Adjusted operating margin rebounded to 13% in Q4, targeting 15% by year-end, after prior margin compression from veterinary inflation.

• Capital allocation is now more disciplined, prioritizing profitability over growth, with a lag expected in growth acceleration as PAC spend is gradually increased.

• 60-month plan targets 25% year-over-year growth in revenue and intrinsic value per share by 2025, with current revenue CAGR at 26%.

• Pets Best segment is in secular decline, freeing up capital for core business, with revenue growth now driven by ARPU rather than pet count.

Strategic priorities and growth initiatives

• Focused on sustainable, member-centric growth, aiming to double enrolled pets from 1 million to 2 million, with a strong emphasis on efficient PAC deployment and prudent capital allocation.

• International expansion has doubled the addressable hospital market to 50,000, with recent launches in Germany, Switzerland, Belgium, Poland, and ongoing scaling in Australia and Czech Republic.

• Vet channel remains the core growth engine, with a 23% year-over-year increase in vet leads and higher conversion and retention rates compared to non-vet channels.

• Distribution partnerships with State Farm, Aflac, and Chewy are being prioritized and modeled for capital efficiency, targeting new pet parents outside the vet channel.

• Advanced data tools enable granular, neighborhood-level targeting for marketing and pricing, optimizing growth in profitable segments.

Market dynamics and competitive landscape

• Veterinary inflation remains high at 15%, compressing margins but also increasing the need for pet insurance; Trupanion’s claims trend does not perfectly track CPI due to broader coverage and higher utilization.

• Market penetration is still low (~4%), with the largest competitor being non-insurance (credit cards), and new private equity entrants expected to raise category awareness and normalize insurance adoption.

• Trupanion’s differentiation is built on direct vet payments, strong vet relationships, and a focus on high-quality, sustainable pricing, especially as competitors often underprice and later raise rates.

• International markets are being Trupanionized with local adaptations, leveraging data from North America and Australia, and adjusting pricing dynamically where regulatory environments allow.

• Product and process innovation, including the Vet Portal and public health data initiatives, are enhancing operational efficiency and future-proofing the business.